NCI Inc. (NCIT) is in the Technology Industry

• Sort by
• View by Content Type

• NCI Inc. Q3 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Operator Instructions. Your first question is from William Loomis – Stifel Nicolaus & Company, Inc. William Loomis – Stifel Nicolaus & Company Just looking at the days sales, Terry, let me get this straight. The BRAC bid is only $30 million in that $202...

  Earnings calls 2008-11-04

  Tags: Staffing, Call Transcript, Quarter, Earnings, NCI Inc., Seeking Alpha

• Six Market Beating Smallcaps to Own

  Market Beating Stocks submits: The market was up very strong last week, with oil again the big story. Oil prices dropped 7.9% last week and are now down 22% from mid July highs. The financial sector also showed gains last week despite negative press from several major firms. That...

  External links 2008-08-11

  Tags: Smallcap, Industrial Services of America Inc., ManTech International Corp., NCI Inc., NN Inc., Olin Corp., Thermadyne Holdings Corp.

• NCI, Inc. Q2 2008 Earnings Call Transcript

  Question-and-Answer Session Operator Operator Instructions Our first question comes from Erik Olbeter – Pacific Crest Securities. Erik Olbeter – Pacific Crest Securities Real quick sort of getting back to some of the work you saw pushed off, I think you sort of talked about the supplemental not...

  Earnings calls 2008-07-29

  Tags: NCI Inc.

• NCI Inc. Q4 2007 Earnings Call Transcript

  Question-and-Answer SessionOperator Operator Instructions. We will go first to William Loomis with Stifel Nicolaus. William Loomis History, thanks. Great quarter. Just looking at the first development side, I think one of the more impressive things just have the pipelines growing and then all the metrics,...

  Earnings calls 2008-02-21

  Tags: NCI Inc.

Additional Resources

• Fabregas ready to deliver

  Byline: By JIM VAN WIJK Sports Correspondent ARSENAL tonight begin a new era under the captai ncy of Cesc Fabregas - who has pledged the young Gunnersmust now "fulfil our potential". Manager Arsene Wenger stripped former Chelsea defender William Gallas of the captaincy and left him...

  Articles 2008-11-25

• Annual Report to the Nation Finds Declines in Cancer Incidence and Death Rates; Special Feature Reveals Wide Variations in Lung Cancer Trends across States

  <?xml version="1.0" encoding="ISO-8859-1"?> <!DOCTYPE text PUBLIC "-//The Gale Group//DTD Mercury Version 1.0//EN" "Article.dtd"> <Text rich="yes"> <P> A new report from the nation &apos; s leading cancer organizations shows that, for the first time since the report was first issued in 1998, both incidence and death...

  Articles 2008-11-25

• Zacks Releases Four Powerful &quot;Buy&quot; Stocks: Briggs &amp; Stratton Corp., Techne Corp., NCI and Zhongpin

  CHICAGO -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value....

  Articles 2008-11-20

• NCI Building Systems Fourth Quarter Fiscal 2008 Conference Call on the Internet

  HOUSTON, Nov. 20 /PRNewswire-FirstCall/ -- NCI Building Systems, Inc. will provide an online, real-time webcast and rebroadcast of its conference call for the 2008 fourth quarter results and outlook on Thursday, December 11, 2008. The live broadcast of NCI's quarterly conference call will be available online...

  Articles 2008-11-20

• NTG Clarity Networks Inc. Announces Third Quarter 2008 Results

  NTG Clarity Networks Inc., (TSX VENTURE: NCI) the supplier of NTS, a world leading OSS operation support system product that enables Telecom and Network operators to manage their networks and assets, reduce time to market for new products and increase profitability, today announced third quarter 2008 revenues of $997,188 compared...

  Articles 2008-11-19

• World&#39;s Top Cancer Research Body Sponsors Landmark COLD-FX(R) Trial

  CV Technologies Inc. (TSX: CVQ) today announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute NCI sponsored trial involving chronic lymphocytic leukemia patients - the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the...

  Articles 2008-11-17

• The Vanderbilt-Ingram Cancer Center Receives CEO Cancer Gold Standard&#153; Accreditation

  CARY, N.C. -- The Vanderbilt-Ingram Cancer Center was accredited with the CEO Cancer Gold Standard([TM]) certification, recognizing the organization's commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines. William C....

  Articles 2008-11-11

• Navigant Consulting Launches Financial Institutions Restructuring Solutions Team

  CHICAGO -- Navigant Consulting, Inc. (NYSE: NCI), a global consulting firm providing dispute, investigative, operational, risk management and financial advisory solutions, today announced that Mitchell D. Kaye, has joined the company as Managing Director. Mr. Kaye will lead the newly created Financial Institutions Restructuring Solutions Team ("FIRST[TM]") on behalf of...

  Articles 2008-11-11

• NCI Partners with Leading Online Provider of Enriched Housing Information for Seniors

  Company Forms Strategic Web Alliance with RetirementHomes.com, Expanding its Mature Living Choices and Senior Living Choices Brands LAWRENCEVILLE, Ga. -- Further expanding online distribution for its advertisers and providing more rich web content for consumers who are searching for their next home, Network Communications, Inc. NCI, the largest...

  Articles 2008-11-11

• Revitilization Continues for Houston Communities

  Cleveland-Ripley Neighborhood Center to Receive Facelift as Part of ARAMARK Building Community, Thurs., Nov. 13 HOUSTON -- Neighborhood Centers Inc. announced today that its Cleveland-Ripley Neighborhood Center, which provides social services to more than 5,000 families in the communities of Pasadena and South Houston, will be enhanced and...

  Articles 2008-11-10

• PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies

  CINCINNATI, Nov. 6 /PRNewswire/ -- PDS Biotechnology Corporation today announced that the company has been selected as a collaborator of the US National Cancer Institute's Nanotechnology Characterization Lab NCL to complete preclinical development of VersamuneTM-HPV prior to filing of the Investigational New Drug Application. The NCL will perform selected...

  Articles 2008-11-06

• NCI completes renovation

  Norman Rijo, president, has announced that NCI Construction, Inc. NCI has completed a full office renovation of a call center for a major Long Island cable operator. During this four-phased project, NCI served as the construction manager, and created a well-designed, practical space for the cable operator. The...

  Articles 2008-11-05

• NCI, Inc. Reports Record Third Quarter 2008 Financial Results

  * Revenues up 19% to $101 million * Organic revenue growth for the quarter of 10% * Operating income up 23% to $7.8 million * Operating margin increases to 7.7% * Third quarter EPS up 30% to $0.32 * DSO...

  Articles 2008-11-03

• Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests

  SUNNYVALE, Calif., Oct. 31 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, and City of Hope Hospital presented today the results from a meta-analysis examining the use of immunohistochemistry IHC to determine the origin of metastatic cancer at the second annual ASCO-NCI-EORTC Meeting on Molecular Markers...

  Articles 2008-10-31

• AMRI Presents Preclinical Data for Tubulin Inhibitor, ALB109564, at EORTC-NCI-AACR Symposium

  ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) reported data resulting from preclinical studies of ALB109564a at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, held October 21-24 in Geneva, Switzerland. ALB109564a is a novel analog from an established and marketed class of tubulin inhibitors, which is designed to kill cancer...

  Articles 2008-10-30

• Navigant Consulting, Inc. Reports Third Quarter 2008 Financial Results

  CHICAGO -- Navigant Consulting, Inc. (NYSE:NCI): * Third quarter 2008 revenues increased 4% year over year to $198 million. * Revenues before reimbursements were $179 million in the third quarter of 2008, an increase of 7% over the third quarter of 2007. * EBITDA...

  Articles 2008-10-30